Dengue Vaccine Market Size to Reach USD 1.28 Billion Globally with Growing CAGR of 11.7% by 2030
Global Dengue Vaccine Market research report contains thorough information about target markets or customers. Analytical study of this market report aids in formulating growth strategies to augment sales and build brand image in the market. This market report supports the business to take better decisions for the successful future planning in terms of current and future trends in particular product or the industry. The key factors of Global Dengue Vaccine Market report consist of primary research, benchmarking studies, secondary research, company profiles, competitive intelligence & reporting, syndicated research, data collection, data processing and analysis, survey design, and survey programming.
The winning Global Dengue Vaccine Market analysis report endows with CAGR (compound annual growth rate) value fluctuations for the specific forecasted period which seems to be helpful in deciding costing and investment strategies. This is a promising, client-centric, and trustworthy market research report which fulfils client’s business needs.
Data Bridge Market Research analyses a growth rate in the dengue vaccine market in the forecast period 2023-2030. The expected CAGR of the dengue vaccine market tends to be around 11.7% in the mentioned forecast period. The market was valued at USD 0.53 billion in 2022, and it would grow up to USD 1.28 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-dengue-vaccine-market&Shri
Dengue vaccine is only recommended for those who previously suffered from dengue fever. It is given as three injections all over a year. A vaccine to prevent dengue (Dengvaxia) has been licensed and is available in some countries for people between the ages of 9-45. The Developing Countries Vaccine Manufacturers Network (DCVMN) is gaining much popularity for its increasing capacity and willingness to advance vaccine clinical development effectively.
Market Definition
Dengue is a mosquito-borne tropical disease that is caused by dengue virus. The symptoms for this condition usually begin 3 to 14 days post infection. Symptoms include vomiting, high fever, muscle & joint pain, headache, and a characteristic skin rash. The World Health Organization (WHO) recommends that the vaccine be only given to people who have confirmed a history of dengue virus infection.
Drivers
- Increasing Incidence of Dengue
Growing incidence of dengue is projected to boost growth of the dengue vaccine market during the forecast period. For instance, as per the Pan American Health Organization, 1,191,815 cases of dengue were stated, wherein 546,589 were laboratory-confirmed and 5,599 were classified as severe dengue in the region of the Americas, between epidemiological week 1 and 22 of 2019. Thus, this boosts the demand for vaccines.
- Growing R&D Activities
The commitment to R&D for vaccine development is one of the most essential strategies to obtain a competitive edge in the dengue vaccines market. Persistent research holds promising potential for the development of next-gen dengue, malaria, and tuberculosis vaccines. Several R&D of live attenuated vaccines is also expected to help in the growth of the market. For instance, in May 2019, the U.S. FDA approved Dengvaxia used for the prevention of dengue disease is caused by all dengue virus serotypes. It is a live attenuated tetravalent chimeric vaccine which is made using recombinant DNA technology. Additionally, Panacea Biotec, a global generic and specialty pharmaceutical and vaccine maker registered in India, has successfully completed phase I/II study of its novel tetravalent recombinant chimeric dengue candidate vaccine DengiAll.
Recent Development:
- In 2021, Takeda Pharmaceutical Company Limited announced the approval of its TAK-003 dengue vaccine candidate by the European Medicines Agency (EMA), which is currently under investigation for the prevention of any outbreaks in individuals aged 4 to 60 years. The company also intends to apply for regulatory approvals in Argentina, Brazil, Columbia, Indonesia, Malaysia, Mexico, Singapore, Sri Lanka and Thailand through 2021.
Key players operating in the dengue vaccine market include:
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi (France)
- Novartis AG (Switzerland)
- GSK plc (U.K.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Takeda Pharmaceutical Company Limited (Japan)
- BIO-MED (India)
- Intercept Pharmaceuticals, Inc (U.K.)
- Emcure Pharmaceuticals Limited (India)
- Changchun BCHT Biotechnology Co. (China)
- Novo Medi Sciences (India)
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-dengue-vaccine-market?Shri
Dengue Vaccine Market Scope
Type
- Live Attenuated Vaccine
- Chimeric Live Attenuated Vaccine
- Inactivated Vaccine
- Subunit Vaccine
- Nucleic Acid Based Vaccine
Treatment
- Diuretic
- Chlorothiazide
- Chlorthalidone
- Hydrochlorothiazide
- Indapamide
- Anti-Allergic
- Cetirizine
- Desloratadine
- Fexofenadine
- Blood Thinners
- Apixaban
- Dabigatran
- Edoxaban
- Others
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the this research report
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
Top Key Topics Covered:
- Strategic Imperatives
- Factors Creating Pressure on Growth
- The Strategic Imperative
- Growth Opportunities Fuel the Growth Pipeline Engine
- Research Methodology
- Scope and Segmentation
- Research Context and Scope of Analysis
- Segmentation
- Other Techniques for This Research Report Management
- Growth Opportunity Analysis
- Growth Drivers
- Growth Restraints
- Introduction
- The Impact of the COVID-19 Pandemic and Post
- Future Growth
- Innovation Ecosystem
Continued…
Browse Detailed Summary of Research Report with TOC: https://www.databridgemarketresearch.com/toc/?dbmr=global-dengue-vaccine-market&Shri
Some of the Most Important Questions Scrutinized in the Business Intelligence Report:
- What are the key growth parameters for this global market during the forecast period?
- Which key players are expected to hold the largest market share over the forecast period?
- Who are the leading vendors and manufacturers in this market?
- What are the key strategies adopted by leading players in the market for business development and geographical expansion?
- Which end-use industries can trigger high demand in the market over the forecast period?
- What are the key segments in this market?
- Which regional player will have anticipated leading the global market in terms of size?
- What is the impact of the novel coronavirus pandemic?
- Which obstacles must new players overcome in order to occupy a major position?
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Editor Details
-
Company:
- The Wire Times
